MRI in Autosomal Dominant Partial Epilepsy With Auditory Features
NCT ID: NCT00072813
Last Updated: 2017-07-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
72 participants
OBSERVATIONAL
2003-11-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patients are eligible for this study if they have a specific form of familial epilepsy that is being studied at Columbia University in New York. Family members without seizures are eligible as well. All the patients in the study will be evaluated at Columbia before participating. Healthy volunteers aged 18 to 55 also may be eligible for this study.
Participants will undergo a medical history and physical examination. During the study, they may have three or four sessions of MRI. During the MRI, patients will lie still on a table that can slide in and out of a metal cylinder surrounded by a strong magnetic field. Scanning time varies from 20 minutes to 3 hours, with most scans lasting between 45 and 90 minutes. Patients may be asked to lie still for up to 60 minutes at a time. As the scanner takes pictures, there will be loud knocking noises, and the patients will wear earplugs to muffle the sound. Patients will be able to communicate with the MRI staff at all times during the scan and may ask to be moved out of the machine at any time. Some scans may be done in a 3 Tesla scanner. It is the latest advance in MRI, with a stronger magnetic field than in the more common 1.5 Tesla scanner. Functional MRI (fMRI) is done while patients are performing tasks, such as moving a limb or speaking. Patients will have an opportunity to practice such tasks before entering the scanner. The fMRI will take about 1 hour.
...
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neuroimaging Predictors of Treatment Failure in Adult New-onset Epilepsy
NCT01320670
Multimodal Functional Neuroimaging in Epilepsy Patients
NCT02132507
Investigation of Human Epileptic Networks by fMRI
NCT03582345
An Examination of Cognitive and Sensorimotor Processes in Patients With Epilepsy
NCT00859794
A Study to Evaluate fMRI of Active DBS Stimulation in Epilepsy
NCT04753983
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Study Population: Patients with autosomal dominant partial epilepsy with auditory features, a newly described syndrome, asymptomatic family members who are gene carriers, and unaffected family members, and normal volunteers.
Design: magnetic resonance imaging, electroencephalography, and magnetoencephalography.
Outcome measures: detection of structural lesions; regional activation patterns on fMRI.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
14 patients with seizures and the LGl1 mutation.
14 family members with the mutation but no seizures.
14 Non-affected family members, who are not carriers of the LGl1 mutation.
30 normal controls selected at NIH, and screened in the CES outpatient clinic with a physical and neurological examination.
Exclusion Criteria
Women who are pregnant.
Subjects under 18.
Subjects with medical conditions other than ADPEAF that may affect brain function.
Subjects taking medications or neuroactive substances that may affect brain function.
Healthy volunteers must be below the age of 55, to reduce the chance of vascular chnages that could affect MRI.
21 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States
Columbia University
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Baker GA, Nashef L, van Hout BA. Current issues in the management of epilepsy: the impact of frequent seizures on cost of illness, quality of life, and mortality. Epilepsia. 1997;38 Suppl 1:S1-8. doi: 10.1111/j.1528-1157.1997.tb04511.x.
Bastos AC, Korah IP, Cendes F, Melanson D, Tampieri D, Peters T, Dubeau F, Andermann F. Curvilinear reconstruction of 3D magnetic resonance imaging in patients with partial epilepsy: a pilot study. Magn Reson Imaging. 1995;13(8):1107-12. doi: 10.1016/0730-725x(95)02019-p.
Bastos AC, Comeau RM, Andermann F, Melanson D, Cendes F, Dubeau F, Fontaine S, Tampieri D, Olivier A. Diagnosis of subtle focal dysplastic lesions: curvilinear reformatting from three-dimensional magnetic resonance imaging. Ann Neurol. 1999 Jul;46(1):88-94. doi: 10.1002/1531-8249(199907)46:13.0.co;2-4.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
04-N-0033
Identifier Type: -
Identifier Source: secondary_id
040033
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.